S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q2 2025

Adar1 Capital Management

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$650M
Total portfolio value
Positions
210
Reported securities
Top Holding
KROS
11.0% $72.0M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
KROSKEROS THERAPEUTICS INC$72.0M11.03%$13.35$11.26-15.7%
11.0%
PTGXPROTAGONIST THERAPEUTICS INC$52.4M8.04%$55.27$131.62+138.1%
8.0%
BOXXEA SERIES TRUST$38.0M5.83%$112.68$117.22+4.0%
5.8%
ZLABZAI LAB LTD$29.7M4.56%$34.97$19.12-45.3%
4.6%
SPYPUTSPDR S&P 500 ETF TR$25.0M3.84%$611.08$744.78+21.9%
3.8%
ABVXABIVAX SA$23.5M3.60%$7.65$144.65+1790.8%
3.6%
ROIVROIVANT SCIENCES LTD$21.9M3.35%$11.27$35.13+211.7%
3.4%
PRTAPROTHENA CORP PLC$20.5M3.14%$6.07$9.69+59.6%
3.1%
CYTKCYTOKINETICS INC$19.2M2.95%$33.04$86.49+161.8%
3.0%
SPYSPDR S&P 500 ETF TR$14.0M2.15%$611.08$744.78+21.9%
2.1%
CGONCG ONCOLOGY INC$13.6M2.09%$26.00$70.36+170.6%
2.1%
BILSPDR SERIES TRUST$12.4M1.91%$88.26$91.44+3.6%
1.9%
BBIOBRIDGEBIO PHARMA INC$11.2M1.72%$43.18$77.19+78.8%
1.7%
IKTINHIBIKASE THERAPEUTICS INC$10.0M1.53%$1.95$1.99+2.0%
1.5%
SEPNSEPTERNA INC$9.0M1.37%$10.57$34.00+221.7%
1.4%
ABUSARBUTUS BIOPHARMA CORP$8.7M1.34%$3.09$4.87+57.6%
1.3%
ETNB89BIO INC$8.6M1.32%β€”β€”
1.3%
IMVTIMMUNOVANT INC$8.6M1.31%$16.00$38.79+142.4%
1.3%
SVRASAVARA INC$8.2M1.26%$2.28$6.22+172.8%
1.3%
XENEXENON PHARMACEUTICALS INC$8.1M1.25%$31.30$60.96+94.8%
1.3%
BIOABIOAGE LABS INC$8.0M1.23%$4.13$25.10+507.8%
1.2%
PCSCPERCEPTIVE CAP SOLUTIONS COR$8.0M1.22%$10.62$11.00+3.6%
1.2%
AMLXAMYLYX PHARMACEUTICALS INC$7.7M1.18%$6.41$18.27+185.0%
1.2%
CTMXCYTOMX THERAPEUTICS INC$7.0M1.07%$2.27$3.82+68.3%
1.1%
TSHATAYSHA GENE THERAPIES INC$7.0M1.07%$2.31$6.53+182.7%
1.1%
SAGESAGE THERAPEUTICS INC$6.6M1.01%β€”β€”
1.0%
RAPTRAPT THERAPEUTICS INC$6.3M0.96%β€”β€”
1.0%
JANXCALLJANUX THERAPEUTICS INC$6.1M0.94%$23.10$15.54-32.7%
0.9%
AAMAA MISSION ACQUISITION CORP$6.0M0.92%β€”β€”
0.9%
IONSIONIS PHARMACEUTICALS INC$5.9M0.90%$39.51$81.80+107.0%
0.9%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (8)

TickerIssuerNotionalSince Filing
SPYSPDR S&P 500 ETF TR$25.0M+21.9%
PRTAPROTHENA CORP PLC$20.5M+59.6%
SPYSPDR S&P 500 ETF TR$14.0M+21.9%
RAPTRAPT THERAPEUTICS INC$6.3M
IONSIONIS PHARMACEUTICALS INC$5.9M+107.0%
VERVVERVE THERAPEUTICS INC$5.3M
CRMDCORMEDIX INC$2.2M
NAMSNEWAMSTERDAM PHARMA COMPANY$2.0M

Exited Positions (8)

TickerIssuerNotional
RAPTRAPT THERAPEUTICS INC$7.3M
ITCIINTRA-CELLULAR THERAPIES INC$6.3M
NVSNOVARTIS AG$5.6M
COHERUS BIOSCIENCES INC$5.5M
AVTEAEROVATE THERAPEUTICS INC$3.7M
BRIDGEBIO PHARMA INC$2.7M
PTCTPTC THERAPEUTICS INC$2.5M
CRGXCARGO THERAPEUTICS INC$1.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CTMXCYTOMX THERAPEUTICS INC$7.0M+6451.2%+68.3%
AVTXAVALO THERAPEUTICS INC$0.4M+947.3%
PCVXVAXCYTE INC$2.7M+665.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.4M+532.6%
PHATPHATHOM PHARMACEUTICALS INC$0.5M+528.0%
ABOSACUMEN PHARMACEUTICALS INC$0.9M+526.7%
THRDTHIRD HARMONIC BIO INC$3.0M+522.9%
WVEWAVE LIFE SCIENCES LTD$0.6M+397.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
RNXTRENOVORX INC$-0.5M-95.9%
FULCFULCRUM THERAPEUTICS INC$-1.1M-89.1%
SWTXSPRINGWORKS THERAPEUTICS INC$-8.0M-88.4%
SMMTSUMMIT THERAPEUTICS INC$-1.7M-88.0%
APGEAPOGEE THERAPEUTICS INC$-3.1M-82.8%
SPROSPERO THERAPEUTICS INC$-0.2M-82.0%
XNCRXENCOR INC$-3.6M-78.4%
JANXJANUX THERAPEUTICS INC$-5.7M-76.6%-32.7%
← Back to Hedge Funds